Association between polymorphisms of LEP, LEPR, DRD2, HTR2A and HTR2C genes and risperidone- or clozapine-induced hyperglycemia

OBJECTIVE: To determine whether genetic polymorphisms related to pharmacodynamics with metabolic adverse effects, namely leptin promoter (LEP) rs7799039, leptin receptor rs1137101, dopamine D2 rs4436578, serotonin 5-HT2A rs6313, and serotonin 5-HT2C rs518147 and rs12836771, are associated with hyper...

Descripción completa

Detalles Bibliográficos
Autores principales: Puangpetch, Apichaya, Srisawasdi, Pornpen, Unaharassamee, Weerapon, Jiratjintana, Napa, Vanavanan, Somlak, Punprasit, Suweejuk, Na Nakorn, Chalitpon, Sukasem, Chonlaphat, Kroll, Martin H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689662/
https://www.ncbi.nlm.nih.gov/pubmed/31496784
http://dx.doi.org/10.2147/PGPM.S210770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689662/
https://www.ncbi.nlm.nih.gov/pubmed/31496784
http://dx.doi.org/10.2147/PGPM.S210770

Ejemplares similares